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ABSTRACT 
Listeria Monocytogenes (L. monocytogenes) is a ubiquitous bacterium that can 
be found in both soil and water. This opportunistic intercellular pathogen is often food-
borne and can lead to serious illness or death of those that are immunocompromised. 
Current medical research into the practical use of this pathogen has revealed that the 
intercellular mechanisms can be exploited to produce a cancer vaccine. Currently L. 
monocytogenes is being studied as a viable candidate for various other cancer vaccines 
and therapies. The purpose of this study is to reduce the downstream virulence factors 
that heavily rely on upregulation of the prfA gene. In this paper the pIMC plasmid is 
used in an attempt to knock-out the untranslated region (UTR) of the prfA gene located 
on the LIPI-1 pathogenicity island of the L. monocytogenes.  
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CHAPTER 1 
Introduction 
Listeria monocytogenes is an intracellular pathogen that causes listeriosis, a 
disease that can range from mild to life-threatening. Several virulence factors enhance 
its ability to infect the human body. These virulence factors can be upregulated by the 5’ 
riboswitch that becomes activated when the environmental temperature surrounding 
the pathogen is raised above 30 degrees C. These virulence factors facilitate the 
pathogenic response that not only accounts for the morbidity of the disease, but 
generates a host immune response. This characteristic of L. monocytogenes infection 
has generated interest in using this pathogen in order to develop new 
immunotherapies. These therapies include vaccines to prevent disease or to suppress 
tumors.    
L. monocytogenes can recruit the body’s immune system in a targeted response. 
This targeted response has allowed for the success of cancer vaccines using L. 
monocytogenes. There is, however, concern that this pathogen could revert to its 
wildtype or pathogenic form. This reversion of L. monocytogenes in an 
immunocompromised patient could be dangerous, resulting in active listeriosis. 
The primary goal of this research project was to investigate the knockout of the 
untranslated region (UTR) of the prfA gene. Knockout of the prfA would, presumably, 
result in a decreased expression of the virulence factors found on the bacterial 
pathogenicity island as well as other genes controlled by PrfA protein. The pIMC plasmid 
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was used to knock out the UTR of the prfA gene, thereby reducing expression of the 
virulence factors of L. monocytogenes.    
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CHAPTER 2 
Literature Review 
Characteristics of Listeria monocytogenes:  
The prokaryote L. monocytogenes is a Gram-positive, low guanine and cytosine 
(GC) ratio, non-spore-forming motile rod in the Firmicutes division of the Bacteria 
Kingdom (Liu, 2008). The Listeriaceae family contains the genus Listeria; a total of 17 
species are described in literature. The 17 species include: L. monocytogenes (Pirie, 
1940), L. grayi (Larsen & Seeliger, 1966), L. innocua (Seeliger, 1981), L. welshimeri, L. 
seeligeri (Rocourt & Grimont, 1983), L. ivanovii (Seeliger et al.,1984), L. marthii (Graves 
et al. ,2010), L. rocourtiae (Leclercq et al. , 2010), L. fleischmannii (Bertsch et al. , 2013), 
L. weihenstephanensis (Lang Halter et al. , 2013), L. floridensis, L. aquatica, L. 
cornellensis, L. riparia and L. grandensis ( Bakker, et al., 2014) L. newyorkensis, and L. 
booriae (Weller, et al. 2015). Both L. ivanovii and L. monocytogenes cause human 
disease, but L. ivanovii more commonly causes disease in ruminant animals such as 
sheep (Guillet, et al. 2010).  
L. monocytogenes causes listeriosis, a potentially fatal disease in humans 
(Goldfine & Shen, 2007). L. monocytogenes can either be found as a single cell or 
formed into short chains. It is a facultative anaerobe and can be motile at certain 
temperatures within the environment. It produces flagella at temperatures less than 
30oC, but is down regulated at temperatures above 30oC (Toledo-Arana et al., 2009). 
Although it is a non-endosporeforming species, it can survive well in harsh 
4 
 
environmental conditions (Labbé & García, 2013), including high salt concentrations, 
acidic conditions, low pH, extreme temperatures and even short periods of desiccation 
(Takahashi, Kuramoto, Miya, & Kimura, 2011).  
L. monocytogenes can thrive in a variety of environments. This bacterium is well 
adapted to life in the soil; it can also infect arthropods and animals. L. monocytogenes 
has been recovered from many environmental reservoirs, including soil, silage, 
groundwater and vegetation. This pathogen can live on decaying organic matter as a 
saprobe (Toledo-Arana et al., 2009). This species evolved through horizontal gene 
transfer; it can shift from a free-living cell in the environment to that of an intracellular 
pathogen in host cells (Cossart & Lebreton, 2014). L. monocytogenes does not require 
many nutrients for growth. The main nutrient requirements are biotin, riboflavin, 
thiamine, thioctic acid and various amino acids. L. monocytogenes does not grow well 
on salt media that only uses glucose as a sole carbon source (Goldfine & Shen, 2007). 
Several clinical methods have been developed to detect the different species of 
Listeria. The basic Gram stain is used to verify the Gram-positive structure. Tumbling 
motility can be detected using a wet mount slide. Basic tests can confirm Listeria; more 
specific assays are designed to determine the actual species.  BioMérieux produces a 
Listeria assay that uses a ten-well test strip for species identification.  This test strip uses 
biochemical reactions to determine DIM (Differentiation /Innocua /Monocytogenes) 
positives and negatives based on the colorimetric test for naphthylamidase. The 
reaction is a result of the bacterium’s response to esculin, α-mannosidase, the 
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acidification of D-arabitol, D-xylose, L-rhamnose, α-methyl-D-glucoside, D-ribose, 
glucose-1-phosphate and D-tagatose to detect the differences of the pathogenic strain 
L. monocytogenes and distinguish it from the more benign L. innocua (Falkow, 
Rosenberg, Schleifer, & Stackebrandt, 2006). Additional laboratory tests include the 
determination of hemolytic activity (L. monocytogenes is weakly β-hemolytic), the CAMP 
test reaction, hippurate hydrolysis, reduction of nitrates, and serotyping using antibody 
detection and more recently PCR (Leber, 2016).  
L. monocytogenes is an opportunistic foodborne pathogen that is transmitted 
through ingestion. It is ubiquitous in the environment and of concern in the food 
industry, because of its ability to grow well in temperatures that range from 4 to 10oC. 
This range allows it to grow at cooler temperatures and thus the species can propagate 
when stored under refrigeration temperatures. It can then be transmitted through 
ready-to-eat foods that do not undergo cooking. Normal food preservation tactics such 
as acidic conditions or high salt concentrations do not prevent the growth of the 
bacterium. L. monocytogenes has various methods to overcome these hostile 
environmental stressors. The move from free-living to intracellular pathogen requires 
virulence factors such as listeriolysin O (LLO), two phospholipase C enzymes (plcA/plcB) 
amongst others (Labbé & García, 2013). Many of these factors are regulated by the prfA 
gene on the pathogenicity island LPI-1 (Schmidt & Hensel, 2004).  
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Epidemiology of Listeria monocytogenes:  
In 2001, listeriosis was added to the Centers for Disease Control and Prevention’s 
(CDC) list of notifiable diseases to improve surveillance. The CDC recommends that all L. 
monocytogenes isolates be sent to the state public health laboratories for subtyping 
(“Listeria (listeriosis) | Listeria | CDC,” n.d.). PulseNet 
(http://www.cdc.gov/pulsenet/index.html ), the national molecular subtyping network 
for foodborne disease surveillance unit, is designed to find links between cases of 
outbreaks in foodborne disease. This facility uses DNA fingerprinting techniques or 
patterns of illness to identify and elucidate local and multistate outbreaks (“Listeria 
(listeriosis) | Listeria | CDC,” n.d.). 
The CDC estimates that in the United States of America there are approximately 
1600 cases of listeriosis that occur annually, and of those, 260 cases are fatal. The CDC 
stated that in 2013, the average annual incidence of listeriosis cases in the United States 
was 0.26 cases per 100,000 individuals. Of the 831 foodborne outbreaks to occur in the 
United States in 2012, there were 4 confirmed listeriosis outbreaks and an additional 
suspected outbreak (“Listeria (listeriosis) | Listeria | CDC,” n.d.).  
Once ingested, the L. monocytogenes bacterium enters the host body, where 
environmental factors induce the upregulation of virulence factors that allow it to grow 
inside the host cell. There are many virulence factors that are upregulated by the shift to 
the host temperature of 37oC (Chakraborty et al., 1992).  Although most infections that 
occur in normal healthy adults are asymptomatic, there are occasionally illnesses 
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resulting in symptoms characterized by muscle aches, nausea, vomiting, fever, and 
fatigue.  L. monocytogenes is generally considered a self-limiting pathogen. However,  it 
can, on rare occasions, spread by passing through the blood-brain barrier and causing 
meningitis (Goldfine & Shen, 2007). Its ability to cross the blood brain barrier, the 
gastrointestinal barrier, and the placental barrier make L. monocytogenes a multi-
systemic pathogen that can colonize many different host tissues. Symptomatic listeriosis 
occurs most often in those that are immunocompromised, making L. monocytogenes an 
opportunistic pathogen (Leber, 2016). 
Listeriosis can present as a systemic or a localized infection. When listeriosis 
manifests as a systemic infection, it can present as septicemia. Listeriosis can cause an 
adult onset form as well as the neonatal/fetomaternal form. This form is thought to 
originate as a bloodborne infection in the mother that then colonizes the placenta, 
resulting in spontaneous abortion, a stillborn fetus, or septicemic syndrome 
(granulomatosis infantiseptica) that occurs in babies that survive to birth. The infection 
can remain asymptomatic in the mother, although it can present as listerial miscarriage. 
Women who experience this often complain of flu-like symptoms prior to miscarriage 
(Liu, 2008). Higher morbidity and mortality rates are associated with early-onset 
listeriosis. Early-onset listeriosis presents in newborns less than seven days after birth. 
(“Listeria (listeriosis) | Listeria | CDC,” n.d.). 
When listeriosis is diagnosed in otherwise healthy adults, it usually occurs in the 
central nervous system (CNS) (50 to 70% of patients), resulting in meningitis or 
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meningoencephalitis. The rate of mortality of brain infections associated with listeriosis 
ranges from 20-60%, depending on other underlying factors associated with the patient 
such as age or immune function  (“Listeria (listeriosis) | Listeria | CDC,” n.d.). 
A variety of foods can become contaminated with L. monocytogenes. Dairy 
products, meats, seafood and vegetables are all potential sources for listeriosis 
transmission (Leber, 2016).  The minimum infective dose is not known, and is very likely 
patient-dependent. It is estimated that 100 colony-forming units (CFUs) is within the 
acceptable risk parameter (Affairs, n.d.). 
L. monocytogenes is ubiquitous in the soil and can contaminate produce before 
or during harvest; this is especially true of produce in contact with the soil. Cantaloupe 
contaminated with L. monocytogenes, originating at the Jensen farm located in 
Colorado in 2011, caused a multistate outbreak of listeriosis (“Multistate Outbreak of 
listeriosis Linked to Whole Cantaloupes from Jensen Farms, Colorado | Listeria | CDC,” 
n.d.). This outbreak involved 147 individuals in 28 states. The five subtypes of L. 
monocytogenes associated with this outbreak claimed the lives of 34 people, including a 
miscarried fetus (“Multistate Outbreak of listeriosis Linked to Whole Cantaloupes from 
Jensen Farms, Colorado | Listeria | CDC,” n.d.). The 147 individuals in this case ranged in 
age from less than a year old to 96 years of age. The reported median age was 76 years 
old, with most infected individuals over the age of 60. Seven of the reported cases were 
related to pregnancy. Four were diagnosed prior to birth; the remaining three were 
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diagnosed in the neonates (“Multistate Outbreak of listeriosis Linked to Whole 
Cantaloupes from Jensen Farms, Colorado | Listeria | CDC,” n.d.). 
Pathophysiology of Listeria monocytogenes: 
L. monocytogenes gains entry to epithelial cells of the gastrointestinal tract using 
surface proteins known as internalin InlA and InlB. InlA binds to the E-cadherin cell 
adhesion molecule, and InlB binds to the hepatocyte growth factor (HGF) receptor of 
the host (Goldfine & Shen, 2007). As shown in Figure 1, the binding of inlA and inlB 
forms a membrane bound vacuole around the L. monocytogenes cell. The Listeria then 
secretes listerolysin O (LLO), phospholipase C (PlcA, and PlcB). LLO is the pore forming 
cytolysin and PlcA and PlcB are two phospholipases that together break down the 
vacuole (Fig. 1) (Liu, 2008).   
L. monocytogenes then replicates inside the cytosol using nutrients obtained 
from the host cell. At this point, it recruits the host cell actin via the actin assembly-
inducing protein (ActA) (Freitag, Port, & Miner, 2009). The polymerization of actin forms 
a “comet” like tail, pushing the bacteria through the host cell’s cytoplasm. After 
reaching the outer edge of the host cell, it pushes against the cellular membrane, 
causing the membrane to extrude into a nearby cell. This extrusion creates an 
invagination into the nearby host cell. A double vacuole forms around the L. 
monocytogenes cell, and the infection process starts over (Goldfine & Shen, 2007). It 
then replicates inside the cytosol of the new host cell. The ability of L. monocytogenes to 
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freely move inside the infected cell, as well as its ability to spread  cell-to-cell, are two 
key factors in the pathogenicity of the species (Liu, 2008). 
Figure 1. Lifecycle of Listeria monocytogenes (Tilney & Portnoy, 1989) 
Genetics of Listeria monocytogenes: 
 When L. monocytogenes adapts from a free-living saprophyte to an intracellular 
human pathogen, it must adapt to multiple environmental changes. Several of these 
changes are thought to upregulate virulence factors. The first is the rise in temperature 
within a host body, which causes the hair-pin loop to denature, exposing the 
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thermoswitch aptamer. The activation of the thermoswitch then upregulates the prfA 
transcription activator. This activator has been identified as controlling the regulation of 
almost all the virulence genes required by L. monocytogenes to replicate and spread 
within the host (Goldfine & Shen, 2007).  
Riboswitches are regulatory messenger RNA molecules that contain two domains 
that are vital to the bacterium’s ability to adapt to a changing environment. The first 
domain is the aptamer domain, and the second is the expression platform domain. The 
riboswitch can bind to small molecules at the aptamer domain in what is called the 
ligand binding pocket. This binding can regulate the production of mRNA for gene 
translation. When an aptamer is bound, the expression platform domain changes 
conformation and the riboswitch can interact with the transcriptional or translational 
process and regulate gene activation (Mandal & Breaker, 2004).  
The thermoswitch in the UTR of the prfA gene is a small hairpin loop. This hairpin 
loop changes conformation when the environmental temperature is greater than 30oC, 
and then breaks the nucleic acid hydrogen bonds to reveal the Shine Delgarno (SD) 
region. This conformation change is what allows the ribosome to bind to the SD region. 
The S-adenosyl methionine (SAM) molecule then binds and activates the prfA gene. This 
trans-acting riboswitch also influences other genes downstream of the pathogenicity 
island (Liu, 2008; Xayarath & Freitag, 2009).  
L. monocytogenes can gain entry into cells through phagocytosis by 
macrophages or induce internalization via the internalin virulence factors InlA and InlB. 
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The internalins belong to a family of leucine rich repeat (LLR) proteins. This family of 
proteins can be further divided into three classes. The first class, in which inlA belongs, 
are proteins that tend to express an LPXTG motif (Leu-Pro-any-Thr-Gly) on their C-
terminus. The C-terminus is also what anchors InlA to the bacterial cell wall. The second 
class includes InlB; this molecule is an 80 amino-acid repeat that forms a weak 
association with the cell wall (Goldfine & Shen, 2007; Liu, 2008). The third class is 
comprised of internalins that do not seem to present any surface domains and are 
therefore secreted only in the extracellular space (Luo, Rauch, K. Marr, Müller-Altrock, & 
Goebel, 2004). The internalins InlA and InlB are the major effectors that allow the 
bacterium to enter nonphagocytic cells. (Liu, 2008).  
One bacterial mechanism of lateral gene transfer that can occur in L. 
monocytogenes is pathogenicity island spreading (PAI).  L. monocytogenes has a 
pathogenicity island known as Listeria pathogenicity island 1 (LIPI-1). This gene cluster is 
thought to be an ancient PAI that has lost the ability to transfer this pathogenic island to 
other strains of Listeria. This pathogenicity island is comprised of a gene cluster of 6 
genes  including  prfA, plcA, hly, mpl, actA, and plcB (Schmidt & Hensel, 2004). These 
genes are upregulated by the PrfA protein and are crucial for the intracellular infection 
and spread of L. monocytogenes. LIPI-1 is only present in L. ivanovii and L. 
monocytogenes (Liu, 2008).  
Once the bacterium has entered the host cell, it must escape the vacuole (see 
Figure 1). The plcA, plcB and hly genes facilitate this escape. The hly gene transcribes the 
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virulence factor listeriolysin O (LLO). LLO is a 60 kDa, cholesterol dependent, pore-
forming hemolysin toxin. To date, LLO is the most virulent factor in L. monocytogenes 
(Goldfine & Shen, 2007). LLO is essential for escaping both the single- and double-
membrane vacuoles. LLO inserts into the cholesterol containing membrane of the 
vacuole and forms 20 -30nm diameter pores. Bielecki et al. (1990) showed that L. 
monocytogenes with the LLO deletions were unable to escape from the vacuole. LLO is 
more active at a pH level of 5.5, the same acidity level as a cytosolic vacuole. In contrast, 
LLO is relatively weak in the neutral pH of the cytosol. This reduced cytotoxicity can 
explain why it can escape the vacuole but does not cause lesions to the host cell itself 
(Liu, 2008).  
The prfA gene is essential for the virulence of L. monocytogenes in the host cell. 
PrfA is a regulatory protein that upregulates more than 18 other genes with at least 63 
additional genes being influenced by the Prfa protein. Without the PrfA protein, hly is 
downregulated and LLO is not produced; therefore, escape from the vacuole is unlikely 
(de las Heras, Cain, Bielecka, & Vázquez-Boland, 2011). The transcription of PlcA forms 
the previously discussed bicistronic segment of the PlcA and PrfA mRNA, which also 
includes the hairpin loop riboswitch. The riboswitch is then denatured at temperatures 
greater than 30oC to activate and upregulate the transcription of monocistronic PrfA 
mRNA segments. This upregulation greatly increases the translation of the PrfA 
regulatory protein (Böckmann, Dickneite, Goebel, & Bohne, 2000). 
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The PrfA protein downregulates the flagellin gene flaA, causing the loss of the 
flagella at host temperatures. With the loss of the flagella, all intracellular movement is 
accomplished through actin filament polymerization, controlled by the actA gene. When 
L. monocytogenes loses the actA gene, such as in an induced mutant ΔactA, the 
bacterium fails to assemble actin filaments and is therefore not motile in the cell 
(Goldfine & Shen, 2007; Liu, 2008). The actA gene is more active in a host cell than in lab 
cultures, suggesting other factors may play a role in actA upregulation (Bamburg, 2011).  
Once the bacterium has formed a double vacuole and successfully infected a 
nearby cell, it must then escape from a double walled vacuole. Upon initial infection, 
LLO, PlcA, and PlcB proteins create lesions for the bacterium to escape the single 
vacuole (Freitag et al., 2009). The plcB gene is positively upregulated by the prfA 
protein, enhancing the bacterium’s ability to escape the double vacuole. In murine 
models with a mutant ΔplcB, the bacterium is less likely to escape the double vacuole 
(Rudnicka et al., 1997). The PlcB protein has the ability to hydrolyze an array of 
phospholipids to facilitate escape. Because PlcB protein activity is zinc dependent, it 
relies on the scavenging of zinc by the protease metallopeptidase enzyme coded for by 
the mpl gene. Once the bacterium is free of the double vacuole it is able to replicate, 
and again recruit actin filaments to begin the cycle over (Goldfine & Shen, 2007; Liu, 
2008).  
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Project Introduction 
 My attempt to knockout the thermoswitch in the untranslated region of prfA 
consisted of assembling a plasmid vector that would disrupt the 5’ UTR of the prfA gene. 
The plasmid pIMC was acquired from Dr. Sarah D’Orazio at the University of Kentucky. 
After construction of the pIMC vector, it was electroporated into electrocompetent L. 
monocytogenes cells. Isolates that grew on selective media after electroporation were 
tested to determine success of the electroporation. 
 The goal of this research was to examine disruption of downstream genes by 
knocking out the riboswitches in the 5’ UTR of the prfA gene. The hypothesis was that by 
disrupting this region, downstream genes reliant on the riboswitches would in turn be 
downregulated. This would be detected by quantitative polymerase chain reaction 
(qPCR).  This downregulation would cause a decrease in genes outside the prfA 
regulation box. We could then attempt to identify novel downregulated genes that may 
assist in the development of safer immunotherapies. 
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Chapter 3 
Materials and Methods 
Acquisition of Strain 19111 
A KwikstikTM with the L. monocytogenes bacterial strain 19111 ATCC (American 
Type Culture Collection (ATCC) 10801 University Boulevard Manassas, VA 20110 USA) 
was aseptically inoculated onto 10 blood agar plates (BAP) that contained 5% sheep’s 
blood. The plates were then incubated at 37oC for 24 hours. A colony from the sample 
was then Gram stained for tentative confirmation.  The isolates were then aseptically 
transferred to sterile 1.5ml Eppendorf tubes with 500µl of 10% sorbitol and 1% fetal 
bovine serum (FBS) solution and stored at -80oC overnight. The samples were inoculated 
on BAP and incubated at 37oC for 24 hours. A single colony was selected for inoculation 
into brain heart infusion (BHI) broth and incubated for 24 hours at 37oC.  
DNA extraction  
 The ChargeSwitch® gDNA Mini Bacteria Kit (ThermoFisher Scientific, Waltham, 
MA) was used to collect the genomic DNA via the ChargeSwitch® gDNA Mini Bacteria Kit 
protocol.  1ml of cultured broth containing L. monocytogenes was centrifuged for 10 
minutes at 11K RCF, to form a pellet. The supernatant was then pipetted off and 
discarded. 5µl of the lysozyme solution(50mg/ml) was added to 100µl of the 
resuspension buffer provided in the kit. This mixture was then added to the bacterial 
pellet and gently pipetted up and down to form a homogenous mixture of cells in 
solution, and this was incubated in 37oC water bath for 10 minutes. A solution of 500µl 
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of lysis buffer and 10µl of proteinase K (one solution per bacterial sample) were added 
together in a clean sterile 1.5ml Eppendorf tube and mixed together by inverting 6 
times. After ten minutes in the 37oC water bath, the 500µl lysis solution was added to 
each tube and the tubes returned to a water bath for incubation at 55oC for 10 minutes. 
Following incubation, 40µl of ChargeSwitch Magnetic Beads in solution were added. This 
was then mixed by gently pipetting up and down before 300µl of binding buffer was 
added and the mixture incubated at room temperature for one minute. After 
incubation, the tubes were placed on a magnetic rack and allowed to rest until a pellet 
formed on the side of the tube. The remaining supernatant was gently removed from 
the tube. The tubes were removed from the magnetic rack and washed with 1ml of 
wash buffer by gently pipetting up and down three times. The tube was then placed 
back onto the magnetic rack and left to rest until a tight pellet had formed. To remove 
the protein and other cellular material, the supernatant was washed leaving only the 
DNA.  The DNA was collected by adding 100µl of elution buffer to the tube. The tube 
was placed on the magnetic rack one final time and the elution buffer containing the 
genomic DNA was collected in a clean sterile 1.5ml Eppendorf tube and placed in the -
20oC freezer for storage.  
PCR  
DNA concentration was determined by Nanodrop (ThermoFisher Scientific, 
Waltham, MA); it was also used to determine both purity (260nm/280nm) and quality of 
the sample. The absorbance of the solution at 260nm compared to the absorbance at 
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280nm is used on the nanodrop to measure purity. After determining the DNA 
concentration of each sample, 200ng/µl of genomic DNA was chosen as the starting 
concentration. 21µl of nuclease free sterile water was added to a 0.2ml tube with a 
puReTaq ready-to-go PCR bead (GE Healthcare and Life Sciences, Pittsburgh, PA). The 
tube was maintained in a cold rack to prevent premature reactions from occurring. 2µl 
of DNA (100ng/µl) was added to the tube, after which 10ng/µl forward and reverse 
primers were added. PCR was set up using a Bio Rad T100 thermocycler (BioRad, 
Hercules, California) with the initial denature temperature of 90oC for two minutes, 
followed by 30 cycles of denaturation at 90oC for 30 seconds, annealing at 55oC for 30 
seconds, and finally, elongation at 72oC for 45 seconds. This was followed by a final two 
minutes of elongation at 72oC.  A 2% agarose gel with a 100bp molecular weight ladder 
was used to identify bands in the 350bp range.   
Plasmid Extraction 
E. coli with the plasmid pKEN mut2 were obtained via Addgene from the 
laboratory of Stanley Falkow & Raphael Valdivia, while pIMC was acquired from Dr. 
Sarah D’Orazio’s laboratory at the University of Kentucky.  The E. coli with the pIMC 
plasmid was grown on Terrific Broth (TB) agar with chloramphenicol (125µg/ml) 
overnight. A single colony was transferred to TB and again allowed to grow overnight at 
37°C.  
A Qiagen plasmid midi prep kit (Qiagen, Hilden, Germany) was used to extract 
the plasmid. 50ml of cells were collected by centrifugation at 12.5K RCF for 20 minutes 
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at 4°C. The pellet was then resuspended using a resuspension buffer. The solution was 
vortexed until the mixture became homogenous. Lysis buffer was then added and then 
mixed by inverting the tube several times. Ice-cold neutralization buffer was then added 
and mixed. The tube was then rested on ice for five minutes. The mixture was then 
centrifuged at 12.5k RCF for 10 minutes and the supernatant was decanted.  
A Qiagen tip20 was equilibrated by adding 10ml of equilibration buffer and 
allowed to empty by gravity flow. The supernatant was transferred to the tip20 and 
allowed to empty by gravity flow. The tip20 was washed twice with wash buffer. This 
plasmid was then eluted with elution buffer. Isopropanol was then added to the elution, 
mixed, and centrifuged at 12.5k RCF for 30 minutes. The supernatant was discarded, and 
the pellet washed with 70% ethanol before centrifuging for 30 minutes at 12.5k RCF. 
The supernatant was discarded, and the pellet allowed to dry. 1X Tris EDTA (TE) buffer 
was added to resuspend the pellet. The mixture was then checked using the Nanodrop 
for DNA concentration.  
Preparing the Vector 
 To prepare the vector, the pKEN plasmid was cut using the restriction enzymes 
XbaI and PstI. These two restriction enzymes cut out the GFP cassette of the pKEN 
plasmid (appendix 5, Fig. 12). The linear plasmid was then amplified by PCR to have one 
sticky end with PstI and the other with EcoRI. To circularize the plasmid, the DNA insert 
was then added to a linearized pIMC plasmid along with the T4 DNA ligase. The vector 
was incubated at 22°C for five minutes.  
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 To insert the knockout into the pIMC plasmid, the plasmid was first cut using the 
sticky end restriction enzymes PstI and EcoRI. The linear plasmid was then circularized 
with the knockout sequences using the T4 DNA ligase. The vector was incubated at 22°C 
for five minutes. 
 To purify the plasmid, the plasmid was electroporated into E. coli and incubated 
overnight on selective media. The E. coli was then transferred to Terrific Broth 
chloramphenicol (125µl/ml) and allowed to grow overnight. Plasmid extraction was 
carried out with the Qiagen plasmid mini prep kit (Qiagen, Hilden, Germany) and 
checked via Nanodrop (ThermoFisher Scientific, Waltham, MA).  
Electroporation   
 To make the L. monocytogenes cells electrocompetent, they were first grown on 
BHI (Brain Heart Infusion) agar overnight at 37°C. A colony was selected and transferred 
to BHI broth before incubating overnight at 37°C. An aliquot was transferred to BHIS 
(Brain Heart Infusion Sucrose) broth and grown at 37°C on a shaker on low speed for 2.5 
hours. Penicillin (10ng/ml) was then added to the BHIS and returned to the shaker for 
two hours. The cells were centrifuged at 12.5K RCF and the supernatant removed, after 
which the cells were promptly washed with a sucrose/glycerol solution before being 
allowed to rest. The cells were then centrifuged at 12.5K RCF and the supernatant was 
removed. 30ml of fresh sucrose/glycerol solution was added with lysozyme (10ng/ml) 
and allowed to activate. The final 30ml of sucrose/glycerol solution was added and the 
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cells allowed to rest. The cells were centrifuged at 12.5k RCF and a 1ml aliquot of 
sucrose/glycerol solution was added.  
 500µl of prepared electrocompetent cells were mixed with 1µl of purified 
plasmid and then added to a 1cm electroporation cuvette. The GenePulser (BioRad, 
Hercules, California) was set to 3000V, 400Ω, and 25µƒ and used to electroporate the 
cells. The pulse lasted for 4-8mS.  After electroporation, the cells were rested in BHIS + 
IPTG (isopropyl β-D-1-thiogalactopyranoside) (50µg/ml) for an hour at 37°C. The cells 
were then plated onto BHIS + IPTG + selective media and grown at 37°C for 48-72 hours.  
PCR Colony Prep 
 A single colony was selected using an autoclaved pipet tip. The tip was rubbed 
onto the bottom of a PCR tube and then into a tube containing BHI. Elution buffer was 
then added to the PCR tube and placed in boiling water for two minutes. The PCR tubes 
were then centrifuged and an aliquot added to a new PCR tube.  PCR was then 
performed on the aliquot and analyzed by gel electrophoresis using a 2% agarose gel.  
RNA Extraction cDNA Amplification 
 To begin the extraction, isolates were first grown on BHI agar overnight at 37°C. 
A colony was selected and transferred to BHI broth and grown at 37°C overnight. The 
broth was then centrifuged at 12.5K RCF for 10 minutes and the supernatant was 
discarded. The lysis binding solution (50µg/ml) was added to centrifuged cells. A 64% 
ethanol solution was then added before mixing gently. This mixture was pipetted into a 
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spin column and centrifuged. The flow through liquid was discarded, and a wash 
solution was then added to the spin column before repeating centrifugation at 12.5k 
RCF. Wash solution was added to the tube and centrifuged leaving a pellet. The 
supernatant was discarded, and the wash step repeated. The spin column was then 
placed in a clean collection tube and a preheated elution buffer (TE) was added. The 
elution solution was centrifuged at 12.5k RCF and 100µl of elution buffer was added 
before repeating centrifugation at 12.5k RCF to maximize RNA precipitation.  
 The DNase treatment was then applied to the RNA elution. 10x DNase buffer was 
added to the elution and then incubated at 37°C for 30 minutes. DNase inactivation 
reagent was then added to the RNA solution. The elution was gently mixed and 
incubated for two minutes. The mixture was then centrifuged and the supernatant 
removed. The pellet was then resuspended and transferred to a new tube.  
qPCR  
The bacterial isolates had been electroporated and grown onto the appropriate 
selective media containing the antibiotics. RNA was extracted from the isolates and 
cDNA was produced. The cDNA was then quantified and standardized to 200 ng/µl. The 
standardized cDNA was added to Promega GoTaq qPCR master mix (Promega 
corporation 2800 Woods Hollow Road Madison, WI 53711 USA) along with the forward 
and reverse primers for each virulence gene on a 96-well qPCR plate. The plate was then 
placed in the ABI 7300 (Applied Biosystems, 850 Lincoln Centre Drive Foster City, CA 
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94404 USA) at 95°C for 10 minutes, followed by forty cycles at 95°C (15 seconds), 60°C 
(30 seconds) and 72°C (30 seconds), and finally 10 minutes at 72°C. 
Sanger Sequencing 
 After the DNA was extracted from the electroporated cells using the Charge 
Switch method, the 5’ UTR region of each isolate was amplified using the primer set 
UTR3_F and UTR_R. The PCR cycle used for the amplification of DNA for Sanger 
sequencing was 95°C for 5 minutes, followed by thirty cycles at 95°C for 15 seconds, 
annealing at 54°C for 30 seconds, and elongating at 72°C for 30 seconds, with a final 
elongation at 72°C for 5 minutes on the Bio Rad T100 thermocycler (BioRad, Hercules, 
California). This amplicon was electrophoresed on a 2% agarose gel and the bands cut 
out and extracted using the Qiagen QIAquick PCR Purification Kit (Qiagen, Hilden, 
Germany). This purified amplicon was then sent to the University of Kentucky’s 
Advanced Genetic Technologies Center for Sanger sequencing. Once the samples were 
processed and the data retrieved, Bio Edit (Tom Hall, Ibis Biosciences, 2251 Faraday 
Avenue Carlsbad, CA  92008) was used to create a contig file from the forward and 
reverse Sanger sequence runs1. The contig file was cleaned up using DNA Dynamo (BLUE 
TRACTOR SOFTWARE, North Wales, UK.).  
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Chapter 4 
Results 
Electroporation Results: 
 The pIMC plasmid with the GFP insert grew as ten colonies on antibiotic selective 
media. The first five samples that had the insert were grown using kanamycin selective 
media. The second five samples that had the insert was grown using tetracycline 
selective media. A total of ten plates of L. monocytogenes with the GFP insert produced 
fluorescence under UV light. No further testing was conducted on these plates.  
After proof of concept was achieved, 80 (500µl) aliquots of the bacterial strain 
19111 ATCC L. monocytogenes were then electroporated over the course of 4 attempts. 
Each attempt consisted of 5 single insertions and 15 double insertions. Of these 80 
aliquots, a total of 62 grew on the antibiotic-containing selective media. There was an 
average of 105 colonies on each plate (Appendix 2, Table 1-4)1. Fourteen attempts at 
electroporation resulted in an arc fault (a voltage jump between the anode and cathode 
instead of through the cuvette) that resulted in no colonies being produced since 
electroporation did not occur. In the first attempt several isolates produced no colonies 
even though an arc fault had not occurred. In the second attempt, several isolates 
produced colony growth. In the third and fourth attempts, multiple isolates produced 
                                                            
1 All tables and figures are presented in the appendices following the thesis. 
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colonies and were tested via colony PCR method for the correct insert. In the fourth 
attempt, a single isolate showed the proper bands when colony PCR was performed.     
Sanger Sequencing: 
 The designed PCR products were 425bp, which included base pairs in the plcA 
and prfA genes to ensure the entire UTR was captured. In the first attempt, colonies 
grown on antibiotic-containing selective media were sent for Sanger sequencing. The 
results from this Sanger sequence (Appendix 3, fig. 2 - 10) had multiple errors, large 
gaps and sequences from the control. No viable data was collected. 
 The second attempt at Sanger sequencing produced multiple errors and the 
resultant sequences ranged from 130 to 360bp. Several chromatographs showed poor 
results with less than the target 350bp. Once the contig files had been compiled and 
truncated, less than 180bp were viable on most of the sequences. 
qPCR Results: 
 Unfortunately, the qPRC failed. The first qPCR produced no amplification. In the 
second attempt at qPCR, the machine failed and we were forced to abort this attempt. 
In the final attempt, data was acquired, but produced results that were not linear, and 
no relative quantification was seen. This data is not included, due to being performed at 
the University of Kentucky by a fellow graduate student. 
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Chapter 5 
Discussion 
 The goal of this project was to downregulate the riboswitch in the 5’ UTR region 
of the prfA gene by disrupting the hairpin loop thermoswitch. By downregulating the 
prfA gene, we could then look at virulence factors to confirm downregulation and look 
for previously unknown genes that would be also be downregulated. While it is known 
that downregulation can affect virulence factors, this study wanted to examine growth 
factors also, but we were unable to make it to that point.   
 L. monocytogenes with the GFP inserts were shown to successfully fluoresce 
under UV light. This was considered to be an indication of insertion into the genome. 
However, no further testing was conducted. It was assumed that the knockout of the 
untranslated region would be successfully transformed. This was a mistake for two 
reasons. First, the plasmid may have been inserted by the GFP cassette, but not taken 
up by the genome. The second, even if the GFP cassette had inserted into the genome, 
it may not have been a stable construct.  
 Several knockout vectors were then designed that should affect the riboswitch in 
different ways. The first was to disrupt the riboswitch causing it simply to form 
incorrectly; the second was an attempt to increase the G and C content to prevent the 
hairpin loop from opening, and the third was an attempt to disrupt the promoter prior 
to the riboswitch. 
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 Each knockout vector was electroporated into the electrocompetent L. 
monocytogenes and the bacteria allowed to grow for 72 hours. Because the isolates 
grew successfully on antibiotic selective media, it is believed the plasmid inserted into 
the L. monocytogenes chromosome, but not at the correct location.  Wild type isolates 
grew successfully after electroporation on LB media within 24 hours, but there was not 
any growth of wild type on selective media within the 72-hour time frame.  
 The pIMC plasmid is an excellent choice for insertion of genes into the genomic 
DNA of Listeria because of the phage integrase sequence. The pIMC vector also has 
three variants each contain a different selectable marker. These selectable marker 
antibiotics are kanamycin, erythromycin, and tetracycline. This makes the pIMC plasmid 
versatile in which a double insert can be placed into a single bacterial cell. While pIMC 
would have been a good choice for the insertion of a gene, it was not appropriate to 
manipulate the UTR of the prfA gene in the L. monocytogenes. pIMC has a default 
location in which it inserts the gene of interest; this is why insertion of the GFP cassette 
worked, but the riboswitch knockouts were unsuccessfully transformed in the correct 
location. A better choice would have been to create an insert for a plasmid such as 
pKSV7, which does not have the specific location for insertion that pIMC has.   
Four attempts were made to insert the pIMC vector containing one of the five 
inserts into the electrocompetent L. monocytogenes. Each attempt resulted in colony 
growth on the selective media. It was determined that the pIMC vector was inserting at 
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the wrong location in the genome, and therefore could not be used to disrupt the 
riboswitch.  
On the fourth run, a single isolate produced two positive results when colony 
PCR was performed. This colony PCR was used to amplify the mutated region of the 5’ 
UTR to inside the prfA gene. It was thought that only a mutant would present with 
bands. Since it is highly unlikely any mutations occurred within the 5’ UTR region, these 
bands would need to be sequenced to determine why these two colonies produced 
bands.  
 Sanger sequencing was performed after the first and third electroporation. 
Neither sequencing produced usable sequences, as they resulted in sequences that had 
many gaps and possible erroneous nucleotide insertions and deletion.  
 qPCR was attempted multiple times, but none were successful. In the first 
attempt the machine failed and had multiple errors. In the second attempt the reagents 
may have been out of date, resulting in no data. The final attempt failed because the 
qPCR machine would not link to the computer and thus had to be aborted.  
 Our hypothesis was that manipulating the 5’ UTR region of the prfA gene could 
cause further downregulation of genes, leading to potential immunotherapy and cancer 
vaccination. Further research could include redesigning the correct insert and using a 
different plasmid, or by using these prfA mutants to get a base line of qPCR data for 
further research. Finally, using illumina miseq to collect, analyze and compare gene data 
of wildtype prfA, mutant prfa, and 5’ UTR mutant L. monocytogenes. 
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Procedures that should have been performed 
 One of the first things that should have been performed was to grow the GFP 
insert on LB media to determine the transformation efficiency. It would have been 
simple to determine how many colonies on the plate were fluorescent compared to 
those that were not. This alone would have allowed me to quantify the efficiency of the 
electroporation. Had I combined this with heat shock I could have determined the 
efficiency of electroporation versus heat shock.  
 The plasmid pIMC was not the correct choice for this project. While it is designed 
to insert a gene into L. monocytogenes, it was not designed for the type of knockout I 
had planned. I feel that the reason the GFP insert was successful and the 5’ UTR 
knockout was due to the location where the insert was placed in the genome. Had I 
used a vector such as pVS7 with a ~1000bp before and after, I believe that it would have 
indeed inserted in the correct location.  
 More data should have been collected on the knockout colonies themselves. The 
growth process took an extra 24 hours for some isolates. However, I did not account for 
that in my data collection. I instead just waited 72 hours to collect positive results. I feel 
that if I had thought that the insertion was at the wrong location and that the insertion 
could still be affecting the growth of the L. monocytogenes, I would have viewed this as 
more relevant.  
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 Additionally, I would have performed multiple qPCR runs on many of the growth 
genes to see if any downregulation had occurred after the insert. Had any of the qPCR 
data been salvageable, it may have shown down regulation of the virulence genes even 
though the insert was not in the desired location. Unfortunately, the qPCR data was not 
able to be interpreted.  
 Finally, Sanger sequencing of the pIMC location could have confirmed that the 
insert was transformed into the electroporated L. monocytogenes. This could have 
confirmed that the isolates were successfully transformed. While this was not the 
ultimate goal of this project, conformation of the insert would have been very desirable. 
This would have provided evidence that the insert was in the L. monocytogenes.   
Future direction 
 There are two very appropriate ways to approach future endeavors of this 
project. The first is of course to use the correct plasmid. This could easily be done by 
simply using the inserts previously designed in this project and continuing where I left 
off. I would lay the project out a little different. Knowing what I have learned I feel that 
inserting the GFP with the new plasmid may not be successful unless the entire cassette 
is inserted, not just the GFP gene. Since the new plasmid will be designed to insert into 
L. monocytogenes, it would just be a matter of designing the insert to include 1000bp 
prior to and after the 5’ UTR of prfA. The regions of prfA and pclA would be highly 
conserved and primers quickly designed from the NCBI database. By cloning the 1000bp, 
designing the new knockout region, and then using Gibson assembly to join, all the 
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pieces would come together in the insert. Once this new insert was ligated in the pVS7 
plasmid, it could then be transformed into the electrocompetent L. monocytogenes.   
 The second future direction of this project is to try to determine if the inserts 
have indeed affected the growth of the L. monocytogenes. Several strains of L. 
monocytogenes contain CRISPR. While the insert was not designed to be a CRISPR guide 
RNA, it is possible some aspect of CRISPR caused the slowing of growth. This would be of 
interest because Listeria phages could be designed to carry a sequence into a L. 
monocytogenes bacterium. While this project was not a success in that I knocked out 
the riboswitch, it is worth noting the extended growth time may indicate another 
method to downregulate the virulence factors of L. monocytogenes. 
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Appendix A: 
Primers 
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Table 1. List of primers used in the experiments. 
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Electroporation Tables 
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Table 2 Electroporation Experiment 1. Colony distribution after each attempt at 3000v 
  
Preset 
Voltage 
Resistance Current 
Actual 
Voltage 
Time (mS) Cuvette Colony 
KN1 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN2 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN3 3000V 400Ω 25µƒ 1998 6.7 1mm 1 
KN4 3000V 400Ω 25µƒ 1992 5.7 1mm 0 
KN5 3000V 400Ω 25µƒ 1995 6.4 1mm 0 
KN6 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN7 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN8 3000V 400Ω 25µƒ Arc 0 1mm 6 
KN9 3000V 400Ω 25µƒ 1997 502 1mm 0 
KN10 3000V 400Ω 25µƒ 1998 6.5 1mm 0 
KN11 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN12 3000V 400Ω 25µƒ Arc 0 1mm 2 
KN13 3000V 400Ω 25µƒ 1995 5.2 1mm 0 
KN14 3000V 400Ω 25µƒ 1995 4.8 1mm 0 
KN15 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN16 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN17 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN18 3000V 400Ω 25µƒ 1998 6.5 1mm 0 
KN19 3000V 400Ω 25µƒ Arc 0 1mm 0 
KN20 3000V 400Ω 25µƒ 1992 6.8 1mm 0 
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Table 3 Electroporation Experiment 2. Colony distribution after each attempt at 3000v 
  
Preset 
Voltage 
Resistance Current 
Actual 
Voltage 
Time (mS) Cuvette Colony 
KN1 3000V 400Ω 25µƒ 1998 7.8  1mm 126 
KN2  3000V 400Ω 25µƒ 1998  7.8 1mm 132 
KN3 3000V 400Ω 25µƒ 1997  7.6 1mm 125 
KN4 3000V 400Ω 25µƒ 1992  7.8 1mm 145 
KN5 3000V 400Ω 25µƒ 1998  7.6 1mm 165 
KN6 3000V 400Ω 25µƒ Arc 0  1mm 0 
KN7 3000V 400Ω 25µƒ 1687  6.7 1mm 90 
KN8 3000V 400Ω 25µƒ Arc  0 1mm 0 
KN9 3000V 400Ω 25µƒ Arc  0 1mm 0 
KN10 3000V 400Ω 25µƒ 1968  6.9 1mm 135 
KN11 3000V 400Ω 25µƒ Arc  0 1mm 0 
KN12 3000V 400Ω 25µƒ 1658  5.4 1mm 127 
KN13 3000V 400Ω 25µƒ 1667  5.9 1mm 0 
KN14 3000V 400Ω 25µƒ 1988  6.7 1mm 72 
KN15 3000V 400Ω 25µƒ 1992  6.7 1mm 6 
KN16 3000V 400Ω 25µƒ 1998  5.9 1mm 56 
KN17 3000V 400Ω 25µƒ 1784  6.9 1mm 0 
KN18 3000V 400Ω 25µƒ 1657  5.4 1mm 0 
KN19 3000V 400Ω 25µƒ Arc  0 1mm 0 
KN20 3000V 400Ω 25µƒ 1562  5.2 1mm 0 
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Table 4 Electroporation Experiment 3. Colony distribution after each attempt at 3000v 
  
Preset 
Voltage 
Resistance Current 
Actual 
Voltage 
Time mS Cuvette Colony 
KN1 3000V 400Ω 25µƒ 1999 7.8 1mm 125 
KN2  3000V 400Ω 25µƒ 1998 7.8 1mm 128 
KN3 3000V 400Ω 25µƒ 1998 7.8 1mm 130 
KN4 3000V 400Ω 25µƒ 1997 7.6 1mm 128 
KN5 3000V 400Ω 25µƒ 1998 7.8 1mm 159 
KN6 3000V 400Ω 25µƒ 1998 7.8 1mm 147 
KN7 3000V 400Ω 25µƒ 1998 7.8 1mm 156 
KN8 3000V 400Ω 25µƒ 1954 4.4 1mm 21 
KN9 3000V 400Ω 25µƒ 1944 4.6 1mm 26 
KN10 3000V 400Ω 25µƒ 1965 4.4 1mm 31 
KN11 3000V 400Ω 25µƒ 1975 7.4 1mm 21 
KN12 3000V 400Ω 25µƒ 1966 7.4 1mm 15 
KN13 3000V 400Ω 25µƒ 1998 7.7 1mm 156 
KN14 3000V 400Ω 25µƒ 1998 7.8 1mm 123 
KN15 3000V 400Ω 25µƒ 1997 7.8 1mm 258 
KN16 3000V 400Ω 25µƒ 1996 7.6 1mm 132 
KN17 3000V 400Ω 25µƒ 1996 7.5 1mm 119 
KN18 3000V 400Ω 25µƒ 1998 7.4 1mm 145 
KN19 3000V 400Ω 25µƒ 1985 6.8 1mm 5 
KN20 3000V 400Ω 25µƒ 1988 6.9 1mm 4 
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Appendix C: 
Sanger Chromatograms 
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Fig.2  Isolate KN1F Chromatogram using primer UTR3 with expected length of >350bp 
 
Fig.3 Isolate KN4F Chromatogram using primer UTR3 with expected length of >350bp 
 
Fig.4 Isolate KN6F Chromatogram using primer UTR3 with expected length of >350bp 
 
Fig.5 Isolate KN7F Chromatogram using primer UTR3 with expected length of >350bp 
 
Fig.6 Isolate KN8F Chromatogram using primer UTR3 with expected length of >350bp 
 
Fig.7 Isolate KN10F Chromatogram using primer UTR3 with expected length of >350bp 
 
Fig.8 Isolate KN1R Chromatogram using primer UTR3 with expected length of >350bp 
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Fig.9 Isolate KN2R Chromatogram using primer UTR3 with expected length of >350bp 
 
Fig.10 Isolate KN4R chromatogram using primer UTR3 with expected length of >350bp 
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Appendix D: 
Knockout PCR Gel  
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Fig.11 Colony PCR. Isolates were collected and a primer inside the insert and a primer in 
the pclA gene to look for possible inserts. Wells 12 and 13 show the possibility of an 
insert. (ladder, KN1_1, KN1_2, KN4_1, KN4_2, KN6_1, KN6_2, KN7_1, KN7_2, KN8_1, 
KN8_2, KN10_1, KN10_2, and ladder) 
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Appendix E: 
Plasmid Construct 
50 
 
 
Fig.12 pKEN plasmid construct by Addgene (pKEN GFP mut2 was a gift from Stanley Falkow & 
Raphael Valdivia (Addgene plasmid # 20409)) 
 
 
 
Fig.13 pIMC (Monk, Casey, Cronin, Gahan, & Hill, 2008) given by Dr. D’Orazio lab at the 
university of Kentucky, Lexington, KY.  
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Appendix F 
5’UTR region of prfA 
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Fig.14 5’ UTR Region of the prfA gene with promoters  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
